Cu2+‐Coordinated NLG919: A Drug Delivery Nanoplatform to Activate Antitumor Immunity via Inducing Immunogenic Cell Death and Inhibiting Indoleamine 2,3‐Dioxygenase‐1.
Saved in:
| Title: | Cu2+‐Coordinated NLG919: A Drug Delivery Nanoplatform to Activate Antitumor Immunity via Inducing Immunogenic Cell Death and Inhibiting Indoleamine 2,3‐Dioxygenase‐1. |
|---|---|
| Authors: | Zhao, Lin‐Ping1 (AUTHOR), Huang, Chu‐Yu1 (AUTHOR), Zheng, Rong‐Rong1 (AUTHOR), Zhou, Hang‐Yu1 (AUTHOR), Chen, Guang‐Miao1 (AUTHOR), Ye, Yun1 (AUTHOR), Miao, Ying‐Ling1 (AUTHOR), Li, Shi‐Ying1 (AUTHOR) lisy-sci@gzhmu.edu.cn |
| Source: | Medcomm: Biomaterials & Applications. Sep2025, Vol. 4 Issue 3, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2769643X |
|---|---|
| DOI: | 10.1002/mba2.70024 |
